Title: David Shapiro: Innovator in Pharmaceutical Formulations
Introduction
David Shapiro is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability and effectiveness of various compounds. Although he currently holds no patents, his work has the potential to impact the treatment of several diseases.
Latest Patents
David Shapiro's latest patents include innovative formulations such as "Compositions Of Obeticholic Acid And Methods Of Use." This patent focuses on obeticholic acid formulations that exhibit improved stability, dissolution, and solubility, along with methods for preparing these formulations for therapeutic use. Another notable patent is "Pharmaceutical Combination Comprising 3-Z-[1-(4-(n-((4-Methyl-Piperazin-1-Yl)-Methylcarbonyl)-N-Methyl-Amino)-Anilino)-1-Phenyl-Methylene]-6-Methoxycarbonyl-2-Indolinone And Pemetrexed, And Use Thereof In Cancer Treatment." This invention relates to a pharmaceutical combination useful for treating diseases involving cell proliferation, migration, or apoptosis of myeloma cells, as well as angiogenesis and fibrosis.
Career Highlights
Throughout his career, David Shapiro has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH, where he contributed to various research initiatives. Additionally, he has worked with It's Academic of Illinois, Inc., further expanding his expertise in the field.
Collaborations
David has collaborated with several professionals in his field, including Martin Friedrich Stefanic and Frank Hilberg. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.
Conclusion
David Shapiro is a notable figure in the pharmaceutical industry, recognized for his innovative approaches to drug formulation. His contributions, particularly in the area of obeticholic acid and cancer treatment combinations, highlight his commitment to advancing medical science. His work continues to pave the way for future developments in pharmaceuticals.